These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29411964)

  • 61. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D; Li W; Zhang Y; Zhang B
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
    Zhao H; Li Q; Hong Z
    Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Paclitaxel induces apoptosis in leukemia cells through a JNK activation-dependent pathway.
    Peng ZG; Liu DC; Yao YB; Feng XL; Huang X; Tang YL; Yang J; Wang XX
    Genet Mol Res; 2016 Mar; 15(1):15013904. PubMed ID: 26985944
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
    Zhao F; Yin H; Li J
    Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.
    Liu R; Liu X; Zheng Y; Gu J; Xiong S; Jiang P; Jiang X; Huang E; Yang Y; Ge D; Chu Y
    Oncol Lett; 2014 Nov; 8(5):2193-2200. PubMed ID: 25289099
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.
    Chen L; Cao H; Feng Y
    World J Urol; 2018 Mar; 36(3):357-365. PubMed ID: 29204706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
    Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
    Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy".
    Li X; Lu X; Xu H; Zhu Z; Yin H; Qian X; Li R; Jiang X; Liu B
    Mol Pharm; 2012 Feb; 9(2):222-9. PubMed ID: 22171565
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
    Tang XH; Lu MS; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
    [No Abstract]   [Full Text] [Related]  

  • 74. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
    Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
    J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Wanebo H; Kouttab N; Chu W; Wan Y
    Oncol Rep; 2006 Oct; 16(4):907-13. PubMed ID: 16969513
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ultrasound-Mediated Long-Circulating Nanopolymer Delivery of Therapeutic siRNA and Antisense MicroRNAs Leads to Enhanced Paclitaxel Sensitivity in Epithelial Ovarian Cancer Chemotherapy.
    Liu Y; Long T; Zhang N; Qiao B; Yang Q; Luo Y; Cao J; Luo J; Yuan D; Sun Y; Li Y; Yang Z; Wang ZG
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4036-4050. PubMed ID: 33463352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis.
    Wang C; Xu X; Zhang P; Xiong S; Yuan J; Gao X; Guan W; Wang F; Li X; Dou H; Xu G
    J Nanobiotechnology; 2022 Jul; 20(1):319. PubMed ID: 35799174
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carbon nanotube exposure sensitize human ovarian cancer cells to paclitaxel.
    Zhang W; Zhang D; Tan J; Cong H
    J Nanosci Nanotechnol; 2012 Sep; 12(9):7211-4. PubMed ID: 23035454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ERK-Peptide-Inhibitor-Modified Ferritin Enhanced the Therapeutic Effects of Paclitaxel in Cancer Cells and Spheroids.
    Dong Y; Ma Y; Li X; Wang F; Zhang Y
    Mol Pharm; 2021 Sep; 18(9):3365-3377. PubMed ID: 34370483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.